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SDS
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INTRODUCTION
Molecular genetics has been a popular subject for study in the last few
decades, yielding an ever-expanding body of knowledge about the genome and
new methods with which to obtain and interpret data for genetic analyses. The
most interesting research has focused on the mechanisms of genetic mutations
and its effect on human embryonic development. Among the most engaging
research is the implication that genetics can play an integral part in a variety of
diseases and disorders, including congenital heart disease (Grossfeld, et al. 1999).
Cardiovascular disorders which may be traced directly back to a genetic
defect, familial or germ line, include cardiomyopathies, arrhythmias, connective
tissue disorders, septation defects, laterality defects, outflow tract defects and
both right and left sided obstructive lesions (Grossfeld, et al. 1999). These defects
most often strike their victims during childhood, causing considerable pain and
suffering not only to the patient, but also to the families who care for these
children. In knowing that genetics is linked to a number of congenital diseases, it
is imperative to gain a better appreciation and understanding of the mechanisms
involved so that there is hope for the prevention and treatment of these
devastating malformations.
Of particular interest, genetic defects have long been thought to be one of
many contributors to visceroatrial heterotaxia syndrome (VAH), a critical
developmental disorder of laterality with cardiac involvement which results in
1

neonatal death in the most critical cases unless it is corrected by life-saving
cardiac transplants. In addition to laterality defects in the heart, YAH patients
often have defects in lungs, spleen, liver, where the organs may exhibit a variety
of abnormalities. The normally asymmetrical organ may be on the wrong side of
the longitudinal axis (ie. liver found on the left), reversed (ie. right lobe of lung
has two lobes and left lobe has three), symmetrical (ie. both lungs have three
lobes like the right lung), absent or multiple spleen (ie. asplenia or polysplenia).
or some combination of these defects.
Studies indicate that there have been examples of familial transmittance in
YAH, pointing the proverbial finger to genetics as a potential causation factor.
DNA sequenced from patients with YAH and other heart defects by our group
indicates that some have a mutation or a cluster of mutations in connexin43
(Cx43), the gene that encodes for a gap-junction protein found in many
communication competent cells including cardiac and neural tissues (BritzCunningham, et al. 1995, Dasgupta, et al. 2001).
Britz-Cunningham et al. first documented that five patients had a single
point mutation substituting serine 364 for protein (S364P) in the Cx43 gene
(S364P-Cx43), some independently, others in conjunction with other mutations
located in the carboxyl terminal coding domain of the same gene. These patients
were diagnosed with a severe form of YAH syndrome in which complex heart
malformations are combined with multiple visceral situs abnormalities, all of
2

which result from a failure to establish normal left/right asymmetry. Some
patients also had splenic involvement. Subsequent cell-cell dye-transfer studies
showed that cell lines transfected with the S364P-Cx43 mutant gene formed Cx43
channels that were abnormally regulated.
More recently, Dasgupta et al. used denaturing gradient gel
electrophoresis (DGGE) on heart tissue samples from Hypoplastic Left Heart
Syndrome (HLHS) patients who had received heart transplants. Out of 14
patients, eight children had identical Cx43 mutations involving two silent
polymorphisms and two missense mutations where arginine was replaced by
glutamine at positions 362 and 376. This mutant sequence is identical to the
sequence of the Cx43 pseudogene, and suggests that a rare recombination may
have occurred between the gene (on chromosome six) and pseudogene (on
chromosome five) in these patients and contributed to HLHS. One of these
patients also harbored the S364P-Cx43 mutation on one of its alleles.
The S364P-Cx43 mutation has been explored further through molecular
and developmental studies (Britz-Cunningham, et al. 1995; Levin and Mercola
1998) and it has been determined that indeed it has the capacity to disrupt gap
junctions on a cellular level, however, its effects on a germ-line in-vivo model
and the direct affect of the mutation on embryonic cardiac development has
never been reported. The justification for the creation and analysis of a
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transgenic mouse line is clear. Would the S364P mutation of the Cx43 gene cause
YAH and defects in heart development?
THE MORPHOLOGICAL METHOD
In contemplating the possibilities of the effects of the mutation, it is
important to discuss how cardiac defects, if found, are to be identified and
categorized. Unlike genetic data, which can be quantified, the diagnosis of YAH
is an anatomic description that may be induced in a molecular or cellular model.
but whose effects cannot be described or analyzed with such data. It must be
evaluated and reported qualitatively in a whole animal model.
Criteria for the clinical diagnosis and pathological description of
malformed hearts have had few changes in the last three decades. Not since the
controversial writings of Van Praagh (Van Praagh, et al. 1980) and even earlier
writings by Goor (Goor and Lillehei 1975) has significant progress been made to
establish a uniform means of describing heart malformations. Although this
does not affect the clinical outcome of patients with heart defects, it is difficult for
surgeons to predict what pathology to expect when treating patients with
complex and multiple heart defects, especially if these defects or syndromes are
labeled with non-standardized language (Uemera, et al. 1995). How is medical
science able to communicate if the descriptions and analyses of basic heart
structure appear as a "Tower of Babel" in an age when scientists possess the
technology to clone replacement heart tissue in a petri dish?
4

It appears as if the answer is something that has been often touted by
scholars, but most eloquently said by artist, scientist and part-time philosopher
Leonardo da Vinci, "Simplicity is the ultimate sophistication." Indeed, simplicity
is the key.
Robert Anderson has fervently proposed in both his writings and lectures
for the utilization of the "morphological Method" (Anderson and Becker 1997;
Anderson, et al. 1999) first described by Lev (Lev 1954) and further elaborated by
Van Praagh (Van Praagh, et al. 1964; Van Praagh, et al. 1980) and Goor (Goor and
Lillehei 1975). The logic is simple. Describe what is seen grossly with a
systematic approach that focuses on the general structures and its connections
rather than the infinitesimal sub-components.
In the example of the description of the ventricles, normal or pathologic,
the anatomy of interest can be broken down to its three parts: the inlet, the outlet.
and the apical trabecular component. Using this basic principle, the concept of
the "univentricular" heart is clearly erroneous and outdated, since hidden within
the myocardium of such hearts a space can usually be found with identifiable
trabeculations of the seemingly "missing" ventricle (Van Praagh, et al. 1980;
Anderson and Becker 1997). Functionally, these hearts possess asymmetric
characteristics of both right and left ventricles and should be described simply as
such so that no misunderstandings can arise from the assignment of a fancy and
poorly-descriptive name.
5

Setting basic criteria and using this morphologic approach for reporting
the effects of the S364P-Cx43 mutation would be most advantageous. A picture
may be worth a thousand words, but a good simple description is worth a
million words! The easiest practice to detect and describe the effect of the
mutation on cardiac development would be to follow the method of analyzing
the quality of the left ventricle and its immediate connections to the rest of the
cardiovascular system. Using the standardized procedure, the transgenic line
when compared with a control line, can yield insightful data.
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GAP JUNCTIONS REVISITED
GAP JUNCTIONAL STRUCTURE
Gap junctions are aggregates of channels through which adjacent cells
exchange ions, metabolites, physiologic signals and molecules smaller than IkD,
without utilizing extracellular space (Murray and Fletcher 1984; Stagg and
Fletcher 1990; Godwin, et al. 1993). The low-resistance of the channel facilitates
the rapidity necessary for instantaneous electrochemical transfer from cell to cell.
Each gap junction channel is made up of 12 monomers of one or more
types of connexin protein (Bruzzone, et al. 1996; Kumar and Gilula 1996). Six
connexin protein subunits form one hexameric hemichannel (a connexon) in the
cell membrane. Two opposing connexons, one from each contacting cell, form an
aqueous, hydrophilic gap junction channel that is distinctly separated from
extracellular space. The gap junctions were shown to directly mediate
intercellular communication through the use of affinity purified polyclonal
antibody to these gap junctions. The antibodies were injected into ionically
coupled hepatocytes and effectively eliminated the transfer of fluorescent dye
between adjacent cells. Importantly, when an antibody to gap junctions was
injected into one cell of an eight cell frog embryo, all structures that should have
developed from that cell were abnormally formed or missing (Warner, et al.
1984).
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All vertebrates express multiple connexin genes. In the mammalian gap
junction family, 17 connexin cDNA's have been identified, each with a high
degree of homology with the others. All connexins have four membranespanning domains, two extracellular loops, and a cytoplasmic loop. Both the
amino and carboxyl termini are located in the cytoplasm. The specific sequences
of the connexin genes, especially that of the carboxyl terminus region (Van
Kempen, et al. 1995), are also highly conserved between species.
GAP JUNCTIONS IN DIFFERENT TISSUES AND SPECIES
Interesting enough, the major differences in gap junctions are not between
species but among tissue types. The amino acid sequence in the transmembrane
and the extracellular loops of the protein are well-conserved between tissues and
species. The differences reside in the amino acid sequences of connexins from
different tissue types and are predominantly located in the cytoplasmic loop and
the carboxyl tail (Van Kempen, et al. 1991), areas that are generally accepted as
the gap junction regulatory domains.
Gap junctions are located in many tissue types, especially those that have
cells that are joined to each other in physiological continuity. They can be found
transmitting electrical impulses between cells within an organ or even between
unrelated cells transmitting growth inducer or repressor chemicals from opposite
sides of the developing tissues (Levin and Mercola 1999).
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To date, connexin40, connexiMS, and connexin46 have been identified in
mammalian myocardial cells (Kanter, et al. 1992; Van Kempen, et al. 1995).
Despite the small differences between each gene, each connexin protein forms
uniquely different gap junction channels with specific electrical properties
(Veenstra, 1992). Cx43, however, is recognized as the predominant protein
found in the heart in a variety of species, including humans and all mammals
evaluated. (Beyer, 1987; Fishman, 1990; Van Keppem, 1995). In animal models.
the pattern of Cx43 distribution of the pig and mouse is the most similar to the
human pattern (Van Kempen, et al. 1995). Cx43 proteins are directly responsible
for the electrical coupling of myocardial cells and therefore are the primary
determinant of axial longitudinal resistance (Van Kempen, et al. 1991).
REGULATION OF GAP JUNCTION CHANNELS
The specific method by which gap junctions control cellular
communication is under continual investigation. There have been theories
which examined the contribution of Ca++ and H+ changes in the cell to gap
junction regulation, however these have not been proven to be physiologically
relevant for most tissues. The only undisputed mechanism of Cx43 channel
regulation is phosphorylation by protein kinases (Stagg and Fletcher 1990;
Godwin, et al. 1993; Lampe, et al. 2000), although the known role and sites of
phosphorylation depends on the tissue type, cell-cloning methods, pre-
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experimental phosphorylation state or experimental conditions (Lampe, et al.
2000).
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BACKGROUND ON CONNEXIN43 AND THE S364P MUTATION
CONNEXIN 43 GENE
The connexin43 gene, located on chromosome six, contains 15,000 base
pairs in which exon 2 encodes for a 43-kD gap-junction protein with 382 amino
acids in humans. The topographic structure of Cx43 is like that of the other
members of the connexin family (Kumar and Gilula, 1996).
Humans also carry a Cx43 pseudogene on chromosome five that shares
97% homology with Cx43 (Fishman, et al. 1991). Although the pseudogene is
processed, there is no evidence that a translated protein is produced (Dasgupta,
Martinez et al. 2001).
It is interesting to note that although Cx43 is expressed mainly in the
heart, it is also found in neural, ovarian, uterine, renal, bone and vascular tissues.
In fact Cx43 gap junctions are found in tissues derived from all three embryonic
germ layers. cDNA libraries for Cx43 have been found across species and tissues
from humans to frogs.
REGULATION OF Cx43
Cx43 has a short half-life of one to two hours (Beardslee, et al. 1998).
Short half-lives are common in proteins rich in PEST sequence residues: proline,
glutamic acid, serine and threonine (Darrow, et al. 1995). Cx43 has two such
PEST-like regions between residues 272-285 and 327-340 (Laird, et al. 1991). Due
to the high turnover rate, minor disturbances in the regulation of Cx43 could
11

have a significant impact on the amounts and function of Cx43 in normal cardiac
tissue function(Darrow, et al. 1995) as well as cardiac remodeling (Beardslee, et
al. 1998).
Cx43 is phosphorylated on serine and threonine residues, based on twodimensional gel electrophoresis but the specific residues modified are uncertain
(Laird, et al. 1991). All potential phosphorylation sites are in the cytoplasmic
carboxyl-terminal region of the Cx43 protein (Kanter, et al. 1992; Darrow, et al.
1995).
Lampe et al. recently reported that the phosphorylation of Cx43 is critical
throughout the life cycle of the gap junction. Phosphorylation is one identifiable
regulator of the post-translational trafficking of the Cx43 protein to the plasma
membrane, oligomerization of Cx43 proteins into connexons and assembly of
gap junctional structures as well as the communication properties of single Cx43
channels. Specifically, phosphorylation by active protein kinase C (PKC) appears
to decrease intercellular communication and this has been associated with
phosphorylation of serines 368 and 372. It has also been reported that
phosphorylation of a single connexin protein affects the behavior of the entire
gap junction channel. This confirms the importance of the carboxyl tail
regulatory domain of a single connexin and its effect on the tissue at large
(Lampe, et al. 2000).

12

Mutations with frequencies as low as 8-10% can have dramatic effects on
the regulation of the gap junction channel. Thus, even one altered protein out of
the 12 that oligomerize to make up a gap junction channel can significantly alter
the function of the gap junctions (Dasgupta, et al. 2001).
When critical serines are replaced, Cx43 channels have severely altered
cell-cell communication properties due to the interruption of cyclicAMP (cAMP)dependent protein kinase or protein kinase C-dependent phosphorylation sites
(Stagg and Fletcher 1990; Godwin, et al. 1993). In-vitro studies with cells
expressing the S364P Cx43 mutated protein also show decreased cell-cell
communication (Britz-Cunningham, et al. 1995).
CONNEXIN 43 IN EMBRYONIC DEVELOPMENT
Cx43 is expressed in the early chick blastoderm in a circumferential
pattern, which is integral to left-right (LR) patterning in early development
(Levin and Mercola 1998). The addition of physical interruptions (slits) between
the two sides of the blastoderm's axis resulted in disruption of LR symmetry.
indicating that normal axial development could very well be dependent upon
gap junctional communication across the midline. In situ hybridization assays of
various connexins in early stage embryos also indicated that Cx43 is present
during this early stage. Further tests with antibody to Cx43 showed that the
Cx43 protein directly affected LR symmetry in more than half of the embryos.
This work challenges former theories, which suggest that the two sides of the
13

developing embryo are independent of each other (ie, there is no communication
between them.)
Further evidence of the importance of Cx43 to normal development was
seen in studies using the Xenopus amphibian model where gap junctional
communication is found as early as 8-cell stage embryos (Levin and Mercola
1998). The Xenopus studies demonstrated that cross-midline gap junctional
communication is important for left-right patterning. Disruption in early stage
(4-8 cell) dorsal blastomeres with H7, a chimeric connexin construct that disrupts
gap junctional communication, caused heterotaxia in 29% of the embryos.
Likewise, expression of S364P-Cx43 by early stage dorsal blastomeres also
caused heterotaxia in 23% of the blastula, which is statistically similar to the
heterotaxia caused by H7. Importantly, control animals injected with normal
Cx43 protein had no significant incidence of heterotaxia. This set of experiments
proved that the S364P-Cx43 protein has strong dominant-negative properties in
early embryonic development and impairs channel conductance that results in
the interruption of the embryo's laterality axis.
CONNEXIN 43 IN THE HEART
The expression of Cx43 in the heart varies during embryogenesis. In the
murine heart, Cx43 is expressed in all myocardial cells and has been identified in
the distal conduction system from the distal segment of the bundle branches to
the purkinje fibers (Van Kempen, et al. 1995; Van Kempen, et al. 1996). It is
14

apparently lacking in the sinoatrial node or the atrioventricular node (AVN) at
all stages of embryonic development or in the adult. The pattern of distribution
is similar in humans although there are two notable differences. First, the
density of Cx43 in human ventricles is greater than that of the mouse ventricles.
Second, Cx43 is present more extensively in the conduction system of the adult
human heart. In addition to the areas described in the murine conduction
system, Cx43 can also be found in the proximal bundle branches and the
atrioventricular bundle that immediately follows the Cx43-negative AVN (Van
Kempen, et al. 1995).
In the rat model (Van Kempen, et al. 1996), Cx43 protein is initially found
in the free anterior and lateral walls of the atria and throughout the trabeculae of
the ventricles in dl3-14 myocardium (equivalent to dll in the murine model).
During dl6-20, it appears in the previously incomplete interatrial septum. It has
also been noted that there is a progressive accumulation of the Cx43 protein as
the embryo matures. (Van Kempen, et al. 1991)
The fact that Cx43 is absent in the pacemaker nodal cells of the heart is
interesting. Cx43 has long been thought to influence intraventricular conduction
velocity. In fact, the emergence of gap junctions in murine myocardial cells
coincides with the initial onset of true contractions, around the eighth day of the
mouse's gestation period of 21 days (Navaratnam, et al. 1986; Van Kempen, et al.
1991).
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Cx43 is detected in mouse as early as the 8-cell stage (Stone 1995) and
likely plays a role in organogenesis. Observation of homozygote Cx43 gene
knockout mouse embryos (Reaume, et al. 1995) has shown that the absence of
Cx43 in the heart does not affect the ability of heart muscle to beat. A separate
study attempted to measure the rate of conduction in the Cx43 knockout mice
(Guerrero, et al. 1997), but conduction rates of the homozygote knockouts could
not be accurately determined. However, recordings of the ventricular epicardial
conduction in heterogyzote neonates revealed that their paced beats were 30%
slower than wild type neonates. It appears that while Cx43 is not crucial for
cardiac conduction, it still has an impact on myocardial impulse propagation.
Experiments altering the regulation of Cx43 have produced a variety of
cardiac malformations as well as other developmental abnormalities, especially
in tissues of neural crest origins. Studies examining the under-expression of
Cx43 used Cx43 knockout mice (Reaume, et al. 1995). Although there was an
absence of detectable Cx43 protein and a significant reduction in junctional
communication, there was not a complete absence of cell-cell communication.
The embryos were also capable of surviving, at least prenatally. Postnatally, few
homozygotes were born live and all homozygotes died within minutes to hours
post-birth with cyanosis, labored breathing and a swollen abdomen.
Autopsy of the dead pups revealed a swelling in the region overlying the
right ventricular outflow tract. Compared to the blood-filled cavity in normal
16

pups, the region underlying this swelling in the knockouts was filled with
intraventricular septae myocytes of normal myotubular structure. It is likely that
these swellings obstructed the right ventricular outflow tract leading to cyanosis
and subsequently death in the neonate pups. The only other gross and
histological cardiac defect found in these embryos was hypoplastic right
ventricle. When CMV driven-Cx43 over-expressor transgenic mice were crossed
with the Cx-43 KO animals, there was partial rescue of the fatal phenotype with
some pups surviving for two weeks after birth (Ewart, et al. 1997). The
implication of the knockout's decreased viability and potential rescue indicates
that normal Cx43 is essential to heart development.
Similar studies mimicking the overexpression of Cx43 in murine embryos
have demonstrated increased gap junctional communication in tissues of cardiac
and neural crest origins. (Ewart, et al. 1997; Lo, et al. 1997) The transgenic mice
embryos have cardiac abnormalities similar to those with under-expression of
the same gene. The embryos show evidence of pulmonary stenosis, exaggerated
interventricular cleft, swelling overlying the right ventricular outflow region, a
thickened inter-ventricular septum, abnormal coronary vasculature, and in some
cases a defect resembling an apical ventricular aneurysm which is sometimes
seen as a complication of acute myocardial infarctions in humans. But unlike the
general hypotrophic ventricular myocardium of knockout mice, these embryos
displayed hypertrophy of the ventricular myocardium. In addition to the
17

cardiac defects, the embryos also exhibited non-cardiac abnormalities, including
neural tube defects, disruption of peripheral nerves development and decreased
viability.
Although the precise mechanism is still under investigation, it is clear that
Cx43 is integral to cardiac development and function in many species of animals.
It is also clear that any insufficiency of the protein due to a mutated structure
could have drastic effects on the development and, potentially, the function of
the heart.
BACKGROUND OF THE S364P MUTATION
The S364P-Cx43 mutation is not an isolated event in nature. The protein
for avian Cx43 carries this serine to proline substitution as part of its regular
sequence although avian hearts with gap junctions proteins encoded from this
genetic sequence are considered to be "normal" for these species. No mammals
share this characteristic with avians, as Cx43 is highly conserved within
mammals.
How can it be that birds have a normal, functional heart with a gene
sequence that has so far been found only in humans in conjunction with grave
heart malformations and laterality defects? It is important to note that the
"normal" avian heart structure is very different from that of the human and the
predominant avian cardiac connexin is not Cx43, but Cx42, a homologue of
mammalian Cx40. Cx40 is present in all mammalian heart in varying amounts
18

but its expression appears to be repressed by Cx43 in late embryogenesis (Van
Kempen, et al. 1995).
In humans, the S364P-Cx43 mutation could be an acquired mutation or a
familial one (Dasgupta, Martinez et al. 2001). It is a rare mutation and in the case
of one infant, the S364P-Cx43 mutation was found as one of three separate alleles
for the Cx43 gene. Such mosaicism is rarely the result of an inherited genetic
defect.
The introduction of the S364P mutation in the Cx43 protein appears to be
a simple point mutation, however the nature of the amino acid as well as its
location has the potential to alter the protein in a way that would render it
physiologically nonfunctional. For example, the introduction of proline in a
position that is normally occupied by a serine may alter the secondary structure
of the protein. It is well known that proline produces a near 180° turn between
adjacent amino acids, which could introduce a dramatic kink in the structure of
the protein.
This S364P mutation may also affect the tertiary structure of the protein.
In molecular models of the Cx43 protein, the 364 position is critically located in
the cytoplasmic tail region, which as mentioned earlier, is the regulatory region
of Cx43 gap junction channels. This model suggests that the cytoplasmic
domains may interact with each other, controlling the opening and closing of gap
junction channels. Since the introduction of a proline in the 364 position may
19

produce a kink in the secondary structure this molecular deformity may not
allow normal interactions between adjacent carboxyl tail domains. Whether this
would hold the gap junction in a chronically open or closed position is under
investigation, but it is well known that any disruption in protein regulation
could have adverse effects on the embryo, where regulation and timing of
developmental events is key for normal heart formation.
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THE DEVELOPMENTAL ANATOMY OF THE MURINE HEART
Early experiments studying cardiac dysmorphogenesis relied on
pathologic studies of fully developed abnormal hearts. The focus was placed
upon the end result rather than the early development of these malformations
because little was known about the normal process of heart formation beyond
gross morphological changes (Kirby 1990). More recently, there has been
increasing interest in using mice as a model for development and the
embryogenesis of murine systems has been documented (Kaufman 1995).
Specific focus on heart development has been slower, but the large scale of the
project has limited individual studies to focus on short periods of cardiac
organogenesis or individual segments (ie. the development of atrioventricular
structures from days 10 to 15) rather than the whole heart (Webb, Brown et al.
1998). The recent surge of cardiac research using genetically altered mice has
necessitated documenting normal heart development that would afford a closer
look at the process for comparison. What is known about normal mouse heart
development is concentrated around days 8.5 to term and is spotty at best.
HEART DEVELOPMENT IN THE MOUSE
At day 8.5, the heart is still in the form of a primitive tube formed by the
fusion of the two embryonic dorsal aortae. This tube has several expansions
representing the future locations of the different chambers and their connections.
As mentioned earlier, the heart begins to beat during this stage.
21

By day 9.5, the tubular heart has begun to loop to the right although it is
still unseptated (Webb, Brown et al. 1998). This curvature directs the
atrioventricular canal towards the space where the left ventricle will develop.
The future septi are marked internally by the beginnings of the endocardial
cushions. Externally the area of the interventricular foramen is delineated by an
interventricular groove. Within the primitive ventricle, the myocardium of the
future left ventricle is more developed compared to the future right ventricle.
By day 10.5, the atria are separated by the primary atrial septum. The
ventricles are slightly separated by growth of the muscular ventricular septum
from the apical region of the heart, although in some sections the ventricles
appear to be one common chamber. The proximal ventricular outflow tracts are
not completely separated.
By day 11.5, the tubular heart has looped and chamber formation is clear
(Van Kempen, et al. 1996). In the atria, the second interatrial foramen is visible.
but the definitive rim of the future oval fossa (the fossa created by the postnatal
closure of the foramen ovale) has not yet formed (Webb, et al. 1998). Endocardial
cushions are beginning to fuse in the atrioventricular septal area. There is also
newly derived mesenchyme, formed from the fusion of primary atrial septum
mesenchyme and atrioventricular endocardial cushions, separating the subaortic
and subpulmonary outlets.
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By day 12.5, a fold of the atrial wall has formed the cranial rim of the
future oval fossa and the atrial septum is anatomically complete with the
exception of the foramen ovale, which remains patent until birth (Kaufman
1995).

The ventricular septum continues to grow to separate the left and right

ventricles. The pulmonary infundibulum has begun to appear regionally, but its
origins are mesenchymal, not muscular.
By day 13.5, the atria continue to grow and the complex atrioventricular
septal area is coming together at this stage. The membranous and muscular
components of the interventricular septum are in intimate proximity, but they
may not be fused (Webb, et al. 1998).
By day 14.5, most mesenchymal areas of the heart are becoming
muscularized. The atria have completely extended around the outflow tracts.
but are thin and moderately trabeculated. The right and left ventricular walls
are of equal thickness, although the volume capacity of the left ventricle is
slightly larger. The papillary muscles and chordae tendinaeae cannot be readily
distinguished. The two part interventricular septum (cranial membranous
component from the extension of the bulbar ridges and the caudal muscular
component) is completely fused (Kaufman 1995). The pulmonary veins are
small in the developing embryo and are still unlikely to be seen microscopically
at this stage (Icardo and Sanchez de Bega 1991). The tricuspid valve is missing
the septal leaflet, but the mitral valve flaps are complete (Webb, Brown et al.
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1998). The aortic valve has lowered to the level of the other valves (through a
continual shortening of the subaortic component of the outflow tract).
At this stage, the heart is anatomically complete. Further heart
development is limited to the growth and expansion of the structures and
myocardium in the individual chambers. Blood can be identified in all the
chambers, but due to the presence of the shunt through the ductus arteriosus.
more blood is seen in the right-sided chambers.
ESTABLISHING LATERALITY IN THE HEART
The heart is the first organ to establish left/right asymmetry in the
developing embryo (Levin and Mercola 1998). Research on the anatomy of
defects of laterality has been done on mice homozygous for the inversus
viscerum (iv) gene (Icardo and Sanchez de Bega 1991) and has given some insight
to the morphological characteristics evident in visceral heterotaxy.
Using the same principles established by Van Praagh and modified by
Anderson, the laterality of the heart should be established by looking for the
most constant component of the structure, the one characteristic that is always
present regardless of the severity of heart malformations. The attribute should
also be identified without a qualitative comparison with the arrangement of the
symmetrically opposite structure (Anderson, et al. 1998). Laterality of the
ventricles should be determined by the character of the apical trabeculations.
The right ventricle has coarse apical trabeculations with obvious large
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trabeculations on its septal surface. On the other hand, the left ventricle displays
fine criss-crossing apical trabeculations and its septal surface is smooth instead of
trabeculated.
In humans, the morphological characteristics that differentiate the right
from the left atria are obvious and can be found by comparing the complexity of
myocardium and shape of the atrial appendages. Murine hearts lack atrial
appendages and thus the means for a clear and quick method of determining
atrial right and left-handedness. As an alternative, closer examination of the
atria under light microscopy or SEM at the level of the AV junction is done
(Icardo and Sanchez de Bega 1991). The right atrium appears more globular than
the left and has a blunt inferior border. The left atrium is triangular and
unciform with a comparatively thinner lower border. With a little extra work.
the laterality of the chambers of the murine heart can be elucidated.
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THE EXPERIMENTAL MODEL AND HYPOTHESIS
THE EXPERIMENTAL MODEL
It is established that the S364P mutation does occur in some human
infants with visceroatrial heterotaxia (VAH) syndrome and that the expression of
the S364P-Cx43 mutation disrupts cell-to-cell communication and/or laterality
in development. What has not been explored is whether the mutation by itself is
enough to be a causative factor for VAH. The next logical step is to analyze the
affect of the S364P-Cx43 mutation on cardiac development in a transgenic mouse
line to clarify the role of this defect in heart malformations.

HYPOTHESIS
The serine to proline point mutation of codon 364 site in the connexin43
gap junction gene results in developmental malformations of the heart in the
murine model that may mimic those found in humans (Britz-Cunningham, et al.
1995; Dasgupta, et al. 2001).
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MATERIALS AND METHODS
TRANSGENIC ANIMALS
The transgenic mice were created by Dr. Cecilia Lo at the NICHHD
Transgenic Mouse Development Facility at the University of Pennsylvania,
Philadelphia from constructs designed by Dr. Maithali Shah of Loma Linda
University.
The transgenic construct generated is Cx43-CT/PRO/CMV43/dhfr
(figure 1). This CMV promoter-driven expression vector contains the human
connexin43 sequence in which Ser364 was replaced with proline. A 600 bp
fragment from the 3' untranslated sequence of the dihydrofolate reductase (dhfr)
gene from Toxoplasma gondii was inserted upstream of the SV-40 poly A insert.
The dhfr sequence served as a tag for PCR-based genotyping of embryos.
After qualitative identification of successful insertion, the
microinjection quality DNA was sent to the transgenic facility, where the founder
colony of transgenic mice was made for the present study.
ANIMAL HOUSING
The animals were housed in the Animal Research Facility at the Jerry L.
Pettis Memorial Veterans Affairs (VA) Medical Center. The mice are
individually marked with a numbered metal ear tag. The breeder males are
housed individually in small cages while females are housed individually or in
small groups of no more than four per cage. Pregnant females are kept in
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individual cages so that their pups would be accountable and left undisturbed.
The cages, food and water are changed twice a week.
The mice are placed on standard research-grade rodent chow diets while
pregnant dams and nursing mothers are fed higher fat breeder diets after
confirmation of copulation and maintained until the pups are ready to be
weaned. All animal studies were approved by the Animal Subjects committees
of Loma Linda University and the Jerry L. Pettis VA Hospital using NIH
guidelines.
FOUNDER COLONY MATING PLAN
Heterozygote founder mice (WT/ S364P-Cx43) were inbred to produce
homozygote (S364P-Cx43/S364P-Cx43) and heterozygote (WT/S364P-Cx43)
carriers whose genotypes cannot be distinguished with PCR due to the
preservation of the WT gene on chromosome six in this non-targeted mutation.
Part of the paradox of using transgenic animals is that the location and number
of insertions of the S364P-Cx43 transgene is never known and is always
transmitted alongside a copy of the WT allele. Breedings would yield
heterozygote or homozygote transgenics that are never //true,, heterozygotes or
homozygotes.
These qualitatively genotyped carrier mice were bred with heterozygote
knockout mice (WT/KO) to produce a variety of progeny. The mice with
positive PCR products for both the mutation marker and the knockout marker
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are designated as (S364P-Cx43/KO) and are reserved as parents and inbred for
embryo harvesting. These matings would yield three varieties of genotypes;
homozygote transgenics (S364P-Cx43/S364P-Cx43), homozygote knockouts
(KO/KO) and heterozygote hybrids (S364P-Cx43/KO). Homozygote transgenic
(S364P-Cx43/S364P-Cx43) embryos were harvested for the present study. Any
(WT/WT) offspring were humanely destroyed.
Wild type C57/B6 mice were used as controls. Founder mice were
ordered from Harlan® Laboratories and used as the breeders for control
embryos. The controls were numbered, housed and bred in the same manner
and location as the experimental cohorts.
DNA GENOTYPING
All founder mice and their progeny are genotyped in order to select
suitable candidates for the breeding. At the time of weaning, the mice are
numerically tagged and approximately 1cm of tail is sectioned and processed for
DNA.
The tail clip to be used for animal genotyping is cleaned with isopropyl
alcohol and then placed in a sterile Eppendorf tube. To the labeled tube, 700jiL of
lOOjrg/mL proteinase K in Lazatin lysis buffer (appendix I) is added. The cap of
the tube is covered with an additional layer of parafilm to prevent opening and
desiccation during the heated incubation. The tail clip in buffer solution is then
placed in a 56°C incubator and gently shaken overnight.
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Figure 2. Breeding scheme between the founder colonies (S364P-Cx43/WT & KO/WT) and the
subsequent generations. The resultant liter genotypes are determined by PCR amplification.
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The next morning, the tail should be dissolved with only a few pieces of
hair present. If it has not dissolved, it should be re-incubated with a fresh batch
of proteinase K. After incubation the tube is centrifuged for 20 minutes in 4°C at
14,000rpm. Immediately after spinning, the tube is removed carefully so that the
hair pellet is not disturbed and placed on crushed ice until the next step.
The supernatant (including the clear sticky substance [DNA], but not the
hair pellet) needs to be transferred to a new tube as soon as possible with a sterile
pipette tip. Add 500gL of phenol: chloroform (1:1), cover and gently shake by
hand for three to five seconds. Centrifuge the tube again for two minutes in
room temperature at 4,000rpm until two clear phases can be discerned.
Transfer the top aqueous layer to a clean and labeled Eppendorf tube with
a sterile pipette tip and immediately add 700jiL of cold isopropanol alcohol.
Invert the tube until DNA forms into a thin white threadlike precipitate that
sticks together and eventually pellets and attaches to the side of the tube.
Carefully remove all liquid from the tube while keeping an eye on the DNA
pellet. Allow the tube to air dry for a few minutes so that any remaining liquid is
removed. Then, add 50-100gL of TE buffer to the tube to dissolve the pellet.
Again, seal the cap with parafilm and incubate on a shaker in a 56°C incubator
for at least one hour, or until the DNA pellet has completely dissolved into the
solution. If necessary, more TE buffer can be added in 20gL increments followed
by at least one hour of incubation. After the DNA is successfully dissolved in
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solution it is ready to be used for PCR and must be stored in -20°C Cold storage
will keep the DNA fresh for several months.
PCR AMPLIFICATION
The genomic DNA was subjected to a single round of PCR using three sets
of primers. The separate sets of primers made by Operon® laboratories were
solubilized with 3-D H2O to a 5pmol stock solution. The stock was stored in -4°C
when not in use.
A wild type (WT) primer set was used to amplify the promoter region of
the connexin43 gene (S'-IMRS, 3'-IMR3). The S364-P-Cx43 mutation was tagged
with dHFR and necessitated the use of its own specifically designed primers (5'TS47, 3'-TS28). The knockout was tagged with a neomycin sequence, and part of
the 3' WT gene, which made use of both a neo primer and a WT primer (5,-neo5,/
3'-IMR5).
Sigma® brand Taq polymerase kits, with Taq polymerase and buffers,
were used for PCR amplification. Reaction mixes were made in duplicate with
protocol developed by Dr. Lo (University of Pennsylvania, Philadelphia) with
purified DNA, primers (both 3' and 5'), Dntp mix, 10X buffer, 25mM MgC12, 3-D
FLO, and approximately five units Taq polymerase per reaction tube (Appendix
II). The PCRs were performed using Perkin-Elmer brand Gene Amp 2400 thermo
cyclers.
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PCR REACTION TIMES
For the WT and dhfr primers, 2jiL of DNA was denatured at 94°C for two
minutes. It was then amplified for 35 cycles, each composed of 75 seconds at
94°C, 60 seconds at 58°C, and 75 seconds at 72°C followed by 10 minutes of
extension at 72°C. The PCR products are then kept at 4°C until further use.
For the longer KO neomycin primers, 2|iL of DNA was denatured at 94°C
for three minutes. It was then amplified in 41 cycles, each composed of one
minute at 94°C, two minutes at 60°C, and five minutes at 72°C. Three minutes of
extension time was maintained at 72°C. Again, the PCR products are kept at 4°C
until further use.
PCR GEL ELECTROPHORESIS
The PCR products were prepared for gel electrophoresis by the addition
of 2 jiL of 6X loading dye (Promega® brand) to 10 gL of PCR product. Aliquots
of lOgL were run in individual wells against 2 gL of 1 Kb DNA ladder (Life
Technologies® brand), and similarly prepared positive and negative controls in a
1% aragose mini-gel (appendix I).
ANIMAL MATING
The pair of mice to be mated are placed in the vicinity of each other up to
2 days in advance in order to stimulate ovulation. On the day of breeding, the
mice are placed in the same cage between 16:00 hours and 18:00 hours. The male
is then removed the next morning. The copulation plug in the female must be
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identified with a vaginal probe the next morning before it dissolves. The
removal of the male and the investigation for the copulation plug is best
accomplished between 06:00 hours and 10:00 hours. After identification of the
plug, the female mouse is labeled, placed in its own cage and marked for change
to the breeder diet.
EMBRYO AGE MEASUREMENT
The day of the identification of the copulation plug is denoted as day 0.5.
For example, the 15th day is designated as day 14.5. The embryonic age is an
approximation that could easily be off by +/- six hours. It has been known that
embryos within the same litter can vary in age from several to 24 hours, but this
will not affect the overall analysis of the data, as the hour-to-hour changes are
minor and secondary to the laterality and morphology of the embryo hearts.
EMBRYO HARVEST
The Embryo harvesting should be performed at 12:00 noon in order to
standardize the embryonic age. This is done under the assumption that the mice
mate at 0:00 midnight on the evening of the breeding.
ADMINISTRATION OF ANESTHETIC
At the time of harvesting, the dam is anesthetized with 0.75mL of cold
Avertin cocktail mix (Appendix I) by an intraperitoneal injection with special
care given so that the embryos lying beneath the abdominal wall are not
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disturbed by the needle. The injected dam is arranged in a supine position on
clean paper towels until it is adequately sedated for surgery.
DISSECTION OF DAMS AND EXTRACTION OF EMBRYOS
When the dam is unconscious, the skin in the umbilicus region is lifted
with tweezers and an incision is made through the skin and underlying muscle
layers with sharp dissecting scissors. Through this slit incision, the abdominal
wall is cut open in a V formation by bilateral incisions in a cranial direction to the
rib cage. After cutting, the abdominal wall is deflected to reveal the bicornuate
uterus containing multiple lumps: each lump representing an embryo
surrounded by embryonic tissues.
The uterus is then removed from the dam by separation from its
peritoneal attachments via the ovarian ligaments and the cervix. The
arrangement and number of embryos on each side of the uterus is noted as it is
removed. The entire chain of embryos is washed twice and bathed in KPBS
(figure 3a). The dam is euthanized with an overdose of Avertin cocktail mix and
set aside for proper disposal.
Under a low magnification dissecting scope, the embryos within the
uterus are removed by cutting on one side of oval expansion (figure 3b). The
removed outermost layer is the maternal uterine tissue while the undisturbed
layer underlying this is the embryonic yolk sac. The individual embryos and the
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FIGURE 3. Embryo harvest

Figure 3a
The embryo (seen here magnified
approximately 10X under a dissecting
scope) is surrounded by the muscular
uterus (arrow).

Figure 3b
The embryo is carefully dissected
from the uterus with tweezers and
spring scissors. Special care is given
so that the embryonic sac is not
punctured.

Figure 3 c
After removal from the uterus, the
embryo is seen here with the placenta
(arrow) and a band of maternal tissue
(arrowhead) with covers most of the
embryonic sac.
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yolk sac are gently separated from the uterine tissue and placed in a clean dish
of KPBS (figure 3c).
The band of maternal tissue that surrounds the embryo is gently
separated from the surface of the amniotic sac (figure 4a). The placenta and parts
of the yolk sac intimately adjacent to it are cut from the embryos and discarded
(figure 4b). The remaining yolk sac and the amniotic sac, now deflated and still
surrounding the embryo, are separated from the embryo (figure 4c), rinsed in
clean KPBS and placed in a labeled 1.5 mL micro test tube (Eppendorf) for DNA
genotyping.
Each embryo is then photographed with a Polaroid camera fitted into the
eyepiece of the microscope with a millimeter scaled ruler for reference. Embryos
from days 12.5 through 14.5 are also weighed after gentle blotting with sterile
tissue paper to remove excess moisture from the KPBS bath. Due to the delicate
nature of the smaller embryos (days 9.5-11.5), the blotting and transferring of the
embryos onto the scale would result in severe damage and this measurement
was omitted in the interest of tissue preservation. After these measurements, the
embryos are then re-suspended for an additional hour in KPBS to assure that
when the heart ceases, it will be in the relaxed, uncontracted stage.
Embryo Preservation
After the timed suspension in the KPBS bath, the embryos are placed in
individually labeled tubes or vials containing 10% formalin. They are set aside
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FIGURE 4. Dissection of
Extraembryonic membranes
Figure 4a
After the band of maternal tissues is
cut apart (white arrow), the
embryonic sac (arrowhead) is
revealed. The placenta is also more
apparent (black arrow).

Figure 4b
After the removal of the placenta,
and the adjacent tissues, all that
remains is the embryo surrounded
by a deflated chorion and amnion
(the extraembryonic tissues).

Figure 4c
The extraembryonic tissues (arrow)
can be teased away to reveal the
embryo inside (arrowhead). It is
cut, washed and used for
genotyping. The embryo is then
measured, weighed and then
preserved for microscopy.

for fixation overnight and may be kept in this solution until they are ready to be
embedded, sectioned and stained for microscopy.
EMBRYO GENOTYPING
The extraembryonic membranes must be digested to separate the highmolecular-weight genomic DNA from other substances in the tissue. For this.
700 pL of proteinase K in Lazatin lysis buffer (100pg/ mL) is pipetted into each
tube containing tissues to be digested. The tubes are sealed with parafilm and
are gently shaken overnight in an incubator set at 56°C.
The next day, the DNA is purified by adding approximately 500pL
phenol:chloroform:isoamyl alcohol (25:24:1) to each tube. The tubes are shaken
for a few seconds and spun down in a centrifuge for one minute at 4,000rpm.
The top aqueous layer is removed with a pipette and placed in a clean newly
labeled tube with 700pL of cold isopropanol and inverted gently a few times to
precipitate the long thin glassy DNA strands. When the DNA strands form a
pellet, remove the liquid from the tube, making sure to maintain eye contact with
the pellet and to leave it on the side of the tube. 30 to 80pL of TE buffer is then
added to the pellet to re-suspend the DNA. The tube is then incubated at 56°C
for an hour or until the DNA has satisfactorily re-suspended in the TE buffer.
The DNA can be used immediately for PGR analysis or kept frozen at -20°C
indefinitely.
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CONTROL EMBRYO HARVEST
The harvesting, extraction and preservation of the control litters were
conducted in the same manner as the transgenic litters. The inbred wild type
litters were not genotype d.
CONTROL EMBRYO SELECTION
For each gestational age, the length and weight data for two litters were
compiled and the average and standard deviations were calculated. Three
embryos from each gestational age were chosen for sectioning to represent the
range of embryo sizes. One of mean size, one at one standard deviation above
and one below the mean.
EMBRYO HISTOLOGY TECHNIQUE
Embryos slides were prepared by the Anatomy Department of Loma
Linda University under the direction of John Hough.
The embryos were sectioned transversely in a cranial to caudal direction
in 7|iM intervals beginning at the level of the lower jaw where the aortic arch can
first be identified, through the mid section of the liver, where no additional
sections can be made through the heart. Every fifth section was kept for staining
with hemotoxylin and eosin so that each of the serial sections in the final slides
set are 35gM apart. In the smaller embryos, the orientation was difficult to
establish during the embedding process. Their sections are not perfectly
transverse; in some cases they are similar to coronal sections. The basic structure
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of the heart and its connections, however, can still be discerned, evaluated and
compared with the controls.
DATA CAPTURE
After the slides were prepared, they were photographed with a Zeiss®
Universal Microscope and a 2.5X Nikon objective. A blue filter was used with
the camera to improve the quality of the lighting from the tungsten microscope
lamp.
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DATA
CARDIAC FINDINGS
Embryos homozygous for the S364P-Cx43 mutation were recovered
during embryo harvesting at the rate of zero to two embryos per litter. With the
exception of one (to be described later), all embryos appeared externally healthy
at the time of harvest. They had beating hearts and a cursory notation of the
location of the liver (translucent through the thin developing integument) did
not suggest any incidence of laterality defects.
Qualitative microscopic analysis of the slides from the S364P-Cx43
transgenic embryos from ages 11.5d to 14.5d indicate that there are no gross
abnormalities in cardiac development. The control embryos were also 100%
normal. Specific attention was paid to the development of the inflow tracts,
outflow tracts and the myocardial quality of the ventricles, all of which revealed
normal structural anatomy, and appropriate temporal development. Using the
criteria set up by the morphological method, no identifying characteristics of
visceroatrial heterotaxy could be found.
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WT (dl 1.5)

S364P-Cx43 (dl 1.5)
S364P
Weight
507.1
507.2
507.3
507.4
507.5
507.6
507.7
507.8
507.9
Average
St. Dev.

Length
7.5
7
7.25
6.25
7.25
7.5
7.625
7.25
8
7.291667
0.484123

S364P
Length
Weight
0.0514
7.25
509.1
7.125
509.2
0.053
0.054
7.625
509.3
509.4
0.0541
8
0.0513
509.5
7.375
0.0644
509.6
7.875
0.0594
509.7
8
0.0494
509.8
7.75
509.9
0.0639
7.875
0.057
7.875
509.10.
7.25
509.11
0.0446
Average
0.054773 7.636364
St. Dev.
0.006019 0.328132
S364P
TAverage
TSt. Dev.

Weight

WT
Weight
609.1
609.2
609.3
609.4
609.5
609.6
609.7
609.8
Average
St. Dev.

Length
5.25
6.625
7.125
5.875
6
6.75
5.125
7
6.21875
0.772721

Weight
WT
610.1
610.2
610.3
610.4
610.5
610.6
610.7
610.8
610.9
610.10.
Average
St. Dev.

Length
6.25
7
6.625
6.625
6.5
6.125
5.875
6.75
6.75
7
6.55
0.368932

Weight

Length
6.402778
0.588735

WT
TAverage
TSt. Dev.

Length
7.48125
0.431634

CONTROL
Av. +1SD
Average
Av. -1SD

Weight

Length
6.991513
6.402778
5.814042

Table 1. Length and weight statistics for age 11.5d S364P and WT embryos. Homozygote S364P
embryos and controls selected for microscopy are shaded.
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WT (dl2.5)

S364P-Cx43 (dl2.5)
S364P
Length
Weight
9.37
0.1061
505.1
0.1054
505.2
9.375
9.75
505.3
0.1168
505.4
0.1305
10.125
10.125
0.1172
505.5
9.8
505.6
0.113
505.7
9.9
0.1106
9.875
505.8
0.1115
9.79
Average
0.113888
St. Dev.
0.007977 0.291327

BMI
0.011323
0.011243
0.011979
0.012889
0.011575
0.011531
0.011172
0.011291
0.011625
0.000572

BMI
Weight
Length
S364P
0.0967
9 0.010744
515.1
515.2
0.0976
10.25 0.009522
515.3
0.1016
9.375 0.010837
515.4
0.0702
8.25 0.008509
515.5
0.1066
9.5 0.011221
9 0.009878
515.6
0.0889
0.0968
9.25 0.010465
515.7
515.8
0.1091
9.375 0.011637
0.0107
515.9
0.0963
9
Average
0.095978 9.222222 0.01039
St. Dev.
0.011375 0.533187 0.000951
BMI
S364P
Weight
Length
516.1
0.091
9.125 0.009973
8.75 0.009406
516.2
0.0823
516.3
0.1003
9.5 0.010558
516.4
0.0819
8.875 0.009228
0.0928
9.125 0.01017
516.5
0.0884
9 0.009822
516.6
516.7
0.0882
9.5 0.009284
516.8
0.0806
9.25 0.008714
0.0668
9.125 0.007321
516.9
0.0881
9.875 0.008922
516.10.
0.0724
9.5 0.007621
516.11
516.12
9.8 0.008398
0.0823
0.084592 9.285417 0.009183
Average
St. Dev.
0.009015 0.352339 0.001008

Length
Weight
WT
8.625
0.077
603.1
0.0773
8.875
603.2
0.0906
9.25
603.3
9.5
603.4
0.0818
0.0804
9.25
603.5
8.8
0.0815
603.6
9.375
603.7
0.0848
0.0618
8
603.8
0.0474
8
603.9
8.375
0.061
603.10.
8.805
0.07436
Average
0.013309 0.549975
St. Dev.

BMI
0.008928
0.00871
0.009795
0.008611
0.008692
0.009261
0.009045
0.007725
0.005925
0.007284
0.008397
0.001127

BMI
Length
Weight
WT
0.0941
9.875 0.009529
604.1
0.0106
0.1007
9.5
604.2
9 0.008811
0.0793
604.3
0.0864
9.125 0.009468
604.4
0.0096
8.125
604.5
0.078
8.5 0.009776
604.6
0.0831
9.125 0.009567
604.7
0.0873
0.0092
0.0828
9
604.8
8.375 0.008704
0.0729
604.9
0.084956 8.958333 0.009473
Average
0.008462 0.551985 0.000558
St. Dev.

BMI
Length
Weight
WT
TAverage 0.079379 8.877632 0.008907
TSt. Dev. 0.012245 0.541147 0.001038
Length
CONTROL Weight
0.091624 9.418778
Av. +1SD
0.079379 8.877632
Average
0.067134 8.336485
Av. -1SD
Length
S364P Weight
9.405
TAverage 0.096207
0.01523 0.458727
TSt. Dev.

Table 2. Length and weight statistics for age 12.5d S364P and WT embryos. Homozygote S364P
embryos and controls selected for microscopy are shaded.
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WT (dl3.5)

S364P-Cx43 (dl3.5)
S364P
Weight
Length
506.1
0.0582
8
0.0882
506.2
9.375
0.0732
Average
8.6875
St. Dev.
0.021213 0.972272

BMI
0.007275
0.009408
0.008342
0.001508

S364P
Length
Weight
0.1884
11
513.1
0.2887
12
513.2
0.194
11
513.3
513.4
0.1615 10.0625
0.1664
513.5
10.125
Average
0.1998 10.8375
St. Dev.
0.051598 0.792543

BMI
0.017127
0.024058
0.017636
0.01605
0.016435
0.018261
0.003298

BMI
Weight
Length
WT
0.1418
11.125 0.012746
602.1
10.125 0.012454
602.2
0.1261
10.25 0.012546
602.3
0.1286
10.625 0.013242
602.4
0.1407
0.1322
10.375 0.012742
602.5
10.7 0.013607
0.1456
602.6
0.1486
602.7
10.875 0.013664
0.1487
10.5 0.014162
602.8
0.013146
10.57188
0.139038
Average
0.008955 0.330432 0.000619
St. Dev.
Length
Weight
WT
10.75
607.1
0.1525
11.5
607.2
0.1658
0.1736
11.5
607.3
10.375
607.4
0.1335
10.625
607.5
0.1536
0.1225
10.125
607.6
10.625
0.1492
607.7
0.1597
10.875
607.8
10.75
607.9
0.1616
10.625
0.1353
607.10.
10.775
Average
0.15073
0.015966 0.436208
St. Dev.

BMI
S364P
Weight
Length
517.1
0.2869
12.1 0.023711
0.2424
12
0.0202
517.2
517.3
0.2305
11.75 0.019617
0.1496
10 0.01496
517.4
11 0.018664
0.2053
517.5
0.2175
11.75 0.018511
517.6
Average
0.222033 11.43333 0.019277
0.045258 0.801041 0.002836
St. Dev.

Length
BMI
S364P
Weight
TAverage 0.190585 10.78173 0.017677
TSt.Dev. 0.067859 1.224773 0.055405

BMI
0.014186
0.014417
0.015096
0.012867
0.014456
0.012099
0.014042
0.014685
0.015033
0.012734
0.013937
0.001095

BMI
Length
Weight
WT
0.013621
10.68472
0.145533
TAverage
TSt.Dev. 0.014273 0.395577 0.036082

Length
CONTROL Weight
11.0803
0.159807
Av. +1SD
0.145533 10.68472
Average
0.13126 10.28915
Av.-ISD

Table 3. Length and weight statistics for age 13.5d S364P and WT embryos. Homozygote S364P
embryos and controls selected for microscopy are shaded.
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S364P-Cx43 (dl4.5)

WT (dl4.5)

Length
BMI
S364P
Weight
504.1
0.2647
12.5 0.021176
12.44 0.023457
504.2
0.2918
13 0.022208
0.2887
504.3
504.4
0.3935
13.5 0.029148
12.9 0.02193
0.2829
504.5
12.375 0.022731
0.2813
504.6
12.875 0.022944
0.2954
504.7
12.625 0.022939
0.2896
504.8
0.298488 12.77688 0.023362
Average
0.039526 0.372673 0.106062
St. Dev.

Length
Weight
WT
12
0.2003
600.1
0.2034
12
600.2
12.5
0.2376
600.3
0.2297
12.5
600.4
0.21775
12.25
Average
0.018684 0.288675
St. Dev.

BMI
0.016692
0.01695
0.019008
0.018376
0.017776
0.064722

Length
Weight
WT
12.625
0.2506
601.1
12
601.2
0.2308
0.1936
11.375
601.3
11.175
601.4
0.2355
12.5
0.2333
601.5
12.375
601.6
0.2299
0.2944
13.125
601.7
0.2994
12.375
601.8
0.245938 12.19375
Average
0.0353 0.650103
St. Dev.

BMI
0.01985
0.019233
0.01702
0.021074
0.018664
0.018578
0.02243
0.024194
0.020169
0.0543

Length
BMI
S364P
Weight
0.2695
12.5 0.02156
510.1
0.2934
13 0.022569
510.2
13 0.024138
0.3138
510.3
0.0225
510.4
0.2925
13
14 0.025307
0.3543
510.5
510.6
0.3539
14.5 0.024407
0.3421
14.5 0.023593
510.7
0.3553
14.5 0.024503
510.8
0.0252
0.3654
14.5
510.9
0.3324
14 0.023743
510.10.
12.5 0.021624
0.2703
510.11
0.322082 13.63636 0.023559
Average
0.035707 0.839372 0.001326
St. Dev.

WT
Taverage
TSt. Dev.

BMI
Length
S364P
Weight
TAverage 0.312147 13.27447 0.023457
TSt. Dev. 0.038199 0.797186 0.001829

Weight
0.236542
0.032876

BMI
Length
12.2125 0.019369
0.54078 0.060793

Length
CONTROL Weight
0.269417 12.75328
Av. +1SD
0.236542 12.2125
Average
0.203666 11.67172
Av. -1SD

Table 4. Length and weight statistics for age 14.5d S364P and WT embryos. Homozygote S364P
embryos and controls selected for microscopy are shaded.
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NEURAL FINDINGS
One case of abnormal neural development was documented in a
transgenic embryo aged 12.5d. This embryo had persistence of the anterior
neuropore and the associated anencephaly as well as unequal and
underdevelopment of the eyes. This is evident by the grossly abnormal structure
of the head. Although it was among the smallest of its litter, its length and
weight were within normal limits for its age. These abnormalities were grossly
documented but were not examined further. Sections of the heart of the embryo
did not reveal any abnormal development. There were no gross neural
abnormalities in any of the control litters.
EMBRYONIC SIZE DIFFERENCE
In comparing the weights and lengths between the S364P-Cx43 embryos
and the controls, the transgenics are an average of 0.2-lmm larger than the
control animals. This is insignificant because the controls are of the C57/B6
breed and are generally smaller than the mice used for the transgenic line.
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ANALYSIS
S364P-Cx43 TRANSGENICS HAVE NORMAL CARDIAC DEVELOPMENT
Each of the transgenic embryos homozygous for the S364P displayed
normal cardiac development. All the inflow tracts, outflow tracts, and chambers
of the heart and its connections were normal in morphology. Blood was present
in all chambers in varying quantities at all times, depending on the state of
contraction at the time of death. Chronologically, the milestones of development
in the heart were also normal. The atria and ventricles were morphologically
distinct and complete on day 14.5. The interatrial septum was complete on day
12.5. The interventricular septum was complete on day 14.5. All the leaflets of
the valves (save the septal tricuspid leaflet) were also formed and functional on
day 14.5. All the embryos had beating hearts at the time of harvest.
S364P-Cx43 TRANSGENICS DO NOT AFFECT EMBRYONIC VIABILITY
Their survival to days 11.5 to 14.5 is equivalent with survival to the mid
second trimester to the early third trimester in humans and is testament to the
viability of these transgenic animals. The non-targeted S364P mutation does not
interfere with development of the murine cardiac model up to day 14.5 of the 20
to 21 day long gestation period.
S364P-Cx43 TRANSGENICS DO NOT HAVE DEFECTS OF LATERALITY
The normalcy of the hearts effectively rules out expression of the S364P
transgene as a direct cause of visceroatrial heterotaxy as the laterality of the
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individual chambers is determined early in organogenesis. Examination of the
trabeculations of the ventricles and the shapes of the atria revealed normal
laterality. The position of the liver was grossly noted to be normal and the
splenic conditions were not evaluated in the embryos.
This conclusion is made only with the understanding that such a nontargeted mutation does not replicate the genetic condition in the human patients.
In addition, the transgene is driven by a CMV promoter while normal Cx43 is
driven by endogenous physiologic promoters.
HE S364P TRANSGENE MAY DISRUPT NEURAL CREST DEVELOPMENT
In a case of the single 12.5d old S364P transgenic embryo, there was an
obvious anterior neuropore closure defect. This is a phenomena that was never
seen in more than eight litters of normal control mice. Closure of the anterior
neuropore occurs early in embryogenesis and a defect is associated with
anencephaly and other cranial defects. The eyes of the embryo were also
malformed. They were smaller in size than the control embryos and there was
also a difference in size between the left and right eyes.
The nature of neural tube defects are similar to that of embryos in which
Cx43 overexpression is driven by the CMV promoter (Ewart, et al. 1997). In
embryos overexpressing Cx43, there was selective disruption of neural crest cells.
Some of those embryos had a persistent open neural tube in the area of the
midbrain/ anterior hindbrain. Some also had dysgenesis of the cranial nerve.
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including a reduced oculomotor (III) nerve. While the combination of defects
observed in the S364P embryo are not identical to those found in embryos
overexpressing Cx43, they are similar enough to suggest that the neural crest
cells were indeed disrupted to the point of causing grossly observable pathology.
MORBIDITY AND MORTALITY OF THE EMBRYOS
The morbidity and mortality of the mutations were not documented in
this study, as all the embryos used were harvested prenatally. The breeding of
the founder colony yielded live litter sizes that were comparable to their wild
type counterparts. Had the transgenic litter sizes been smaller, this would not
have posed a problem as transgenic female mice are notorious for high rates of
infertility and low-yield litters. One uncontrollable problem was that the
mothers were left alone with their newborn pups and pups born dead or pups
who died within hours of birth are often cannibalized long before their existence
could be added to the litter tally. The hour of birth is random, and often around
midnight. It would have been impossible to monitor the birth of each of the
dozens of litters.
USE OF THE MORPHOLOGICAL METHOD
In the process of evaluating thousands of slides, the "Morphological
Method" proved to be extremely useful and precise. Strict comparisons between
the transgenes and the controls would have been difficult, as the embedding
orientation and consequently the serial sections of the mice were not identical
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and would not have been useful for comparative data. The study focused on the
identification of defects of laterality and by following the protocol outlined by
Anderson et. al, time was spent gathering only the pertinent data on the right
and left-handedness of the cardiac chambers and its connections.
RISKS OF USING THE TRANSGENIC MODEL
Due to time and monetary constraints, non-targeted mutations were
inserted into transgenic mice created for this study. The associated risks for this
method vary and can be unpredictable making the maintenance and evaluation
of the transgenic animals prone to errors that must be explored, but can never be
fully predicted or appreciated. As long as potential errors and variances are
expected and carefully documented when they are realized, the benefit of using
these models would be to yield a basic set of explorative data in a few months
and for a fraction of the cost of a targeted knock-in mutation. In a manner of
speaking, results from this simplified research would provide the justification for
a larger knock-in study. Such justification would be imperative, as the creation
of a knock-in founder colony alone would involve two to three years of lab work
as well as a six-figure price tag.
The colony used in the S364P mutation study was created using a
transgene carrying the single-point mutation marked with a dHFR tag. This
transgene was randomly inserted into the founder mice's DNA without the
possibility of determining either the number of copies inserted or the location of
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these insertions. Crude qualitative indicators, such as the viability and the
reproductive health of the transgenic mice are used to make sure that little to no
disruptions of any important genes occurred. It is also important to note that
the use of a transgenic line necessitates the understanding that any defects found
in the data could have been a direct result of the random insertion of the
transgene.
CIRCUMVENTING THE PROBLEMS OF GENOTYPING THE TRANSGENICS
One problem associated with the breeding of these non-targeted
transgenic animals is the issue of genotyping. Genetic markers used to amplify
the normal wild type connexin43 gene produce bands on gels for both wild type
and transgenic PCR preparations because the wild type gene remains
undisturbed in the transgenic model. Due to the consistent presence of the wild
type band it is impossible to use this method to determine if the animal is a
heterozygote or homozygote carrier of the mutation, as both would have one
band with both the wild type primers and the dHFR tagged primers. The time
consuming and laborious process of back breeding can help to distinguish
heterozygotes versus homozygotes but it would be extremely inefficient to use
this method for genotyping.
To circumvent this problem, knockout mice were introduced as
intermediate breeders in the breeding for homozygote embryos since it is
impossible to carry both the knockout gene and the mutated gene on the same
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allele. In the last step, breeding two animals, each with a separate knockout
allele and transgenically mutated S364P allele would produce embryos with
three genotypically different types of offspring for embryo harvesting which are
distinguishable by PCR genotyping methods: homozygotic for the S364P-Cx43
mutation, homozygotic for the connexin43 knockout and heterozygote
combination of the two (see figure 2 in the materials and methods section).
The introduction of an altered allele, the KO, is not without its risks.
Although the gene is comparatively small, it is still possible that recombination
could occur during meiosis and affect subsequent generations.
FUTURE STUDIES
Future experiments can focus on the effects of the S364P-Cx43 mutation
on neural crest development. The mutation has already been shown to affect
xenopus embryogenesis, perhaps it will also significantly affect the murine
model and humans. This should also be conducted with the targeted knock-in
mutation and could lead to insightful information about the role of the mutation
in embryogenesis.
Cx43 is undisputedly the most important connexin involved in the
development and viability of the cardiac system. Mutations in the gene should
be explored to the fullest extent since congenital heart defects should be avoided
if at all possible. Although the S364P-Cx43 mutation is rare, the fact that it has

been found in a number of non-related human cardiac transpl~nt patients
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indicates that it may be a causative factor. The non-targetted mutation did not
show conclusive evidence linking the mutation to disease, however, it is only one
of many methods of transgenic study.
The best method of evaluating the effects of the S364P-Cx43 mutation is
the development of a gene-targeted knock-in line. This would provide an in vivo
model that more closely resembles the human genomic defect. A knock-in
transgenic line would also be superior to the non-targeted mutation because the
knock-in utilizes the endogenous promoters and repressors present in the normal
Cx43 gene. Thus, the timing and tissue distribution of gene expression should be
identical to that of wild-type Cx43.
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CONCLUSION
The introduction of a serine to proline point mutation at the 364 position
of the connexin43 gene in the transgenic murine model did not produce
morphologically identifiable cardiac defects in the developing embryos from the
ages of 11.5to14.5 days in utero (equivalent to late second trimester in the
human fetal gestation period). The selected transgenic embryos were compared
with normal controls using a morphological approach, where qualitative analysis
was used to compare and contrast the inlet, outlet and trabecular apical
components of the left ventricle. The only notable deformity is a single case of
anencephaly and associated optical dysgenesis in an embryo, age 12.Sd.
Although the mutation can be held suspect for the failure of closure of the
anterior neuropore, other molecular and breeding conditions cannot be ruled out
as inducers of the deformity.
The S364P mutation of the Cx43 gene, first reported by Britz-Cunningham
(Britz-Cunningham, et al. 1995), was found in patients with visceroatrial
heterotaxia syndrome who exhibited a variety of laterality defects in addition to
those of the heart. The failure of finding signs of left ventricular hyperplasia in
the transgenic embryos cannot exclude this mutation as a causative factor. The
transgene was not specifically targeted, nor was the location of the insertion(s)
and its disruptive potential identified. In addition, the ages of the embryos may
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have been too young for anatomical defects, other than those of laterality, to
manifest grossly.
It would be prudent to repeat the investigation using knock-in mice so

that the S364P-Cx43 mutation would more closely mimic the molecular genetic
situation identified in the human patients. The observation of later-stage
embryos as well as neonatal morbidity and mortality may also prove to be useful
in determining the effect of S364P on cardiac development and embryogenesis.
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APPENDIX I - TEST SOLUTIONS
lM Tris-HCl, pH 8.5
12.lg Tris base
80 mL 3-D H20
Mix the above in a lOOmL flask. Then adjust the pH to 8.5 with 12N HCl
drop wise. Finally, q.s. to lOOmL with 3-D H20.
10% SDS
lOgSDS
lOOmL 3-D H20
In a lOOmL bottle, add lOg SDS. Then, q.s. to lOOmL with 3-D H20 and
mix gently until SDS dissolves. Store in room temperature.
lXTBS
100 mL lOXTBS
900 mL 3-D H20
Mix and store covered in room temperature.
1 % ARAGOSE GEL
lxTBE (from lOx stock)
1 % Agarose (lg/lOOml lxTBE)
Sug/ ml Ethidium bromide (lOµL/lOOmL lxTBE)
Combine the above listed ingredients and microwave until the agarose
has dissolved into solution (approximately 20 seconds to one minute.)
Pour 40mL of hot gel into each minigel tray and insert the well combs.
Cover and let the gel settle and harden in room temperature for at least
an hour before use.
POTASSIUM FORTIFIED PHOSPHATE BUFFERED SALINE (KPBS)
KCl (SOmM in solution)
NaCl
5.51g Na2HP04
0.70g NaH2P04
4 L3-DH20
Mix the above ingredients using sterile techniques. Adjust pH to 7.2-7.4
with lN HCI. Filter through a 0.22 µpore vacuum bottle top filter.

AVERTIN ANESTHESIA COCKTAIL
(Source: Dr. Cecilia Lo, U. Pennsylvania)
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AVERTIN STOCK
10 g 2,2,2 Tribromoethanol
10 mL 2-meth-2-butanol
Mix using aseptic techniques and store in amber colored 1.Sml micro test
tubes (Eppendorf) for protection from light in approximately lml aliquots.
Freeze the stock aliquots at -20°C.
COCKTAIL MIX
100 µL of AVERTIN STOCK
4mLPBS
Prepare fresh by mixing ingredients in ·a foil wrapped blood tube for
protection from light using aseptic techniques. Store on ice until use.
LYSIS BUFFER FOR TAIL CLIPS AND YOLK SACS
(Source: Bien Lazatin, U. Pennsylvania)
BIEN LAZATIN STOCK BUFFER
50mL lM Tris HCL (pH 8.5)
SmL 500mM EDT A
lOmL 10% SDS
20mL5MNaCl
415mL 3-D H20
Mix and autoclave the final solution. May be stored in room temperature.
100 µg/mL STOCK PROTEINASE K
lOOµg Proteinase K
1 mL Lazatin Lysis buffer (see above)
Using aseptic techniques, mix and store in opaque 1.4 mL micro tubes
(Eppendorf) at -20°C.
COCKTAIL MIX
Add and mix lµL of stock proteinase K per lmL of stock buffer. Mix must
be prepared fresh and used immediately.
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APPENDIX II - PCR PRIMERS AND REACTION MIXES
PRIMER SEQUENCES
WT:

IMR5: 5' -ACT TTT GCC CCC TAG CTA TCC C- 3';
IMR3: 5' - CCC CAC TCT CAC CT A TGT CTC C -3'

Dhfr: TS47: 5' - TGT CAC TGT AGC CTG CCA CAA CAC TT - 3';
TS28: 5' - GTC AAT CAG AAC CAA AGC GAG - 3'
KO:

neo5': 5' -GCT TGC CGA ATA TCA TGG TCG C- 3';
IMR5: 5' - ACT TTT GCC CCC TAG CTA TCC C - 3'

PCR REACTION MIX
3' Primer
5' Primer
dNTPMix
lOX buffer
25mMMgCh
TaqEnzyme
Dist. H20

2.SµL
2.SµL
4µL
5µL
4µL
0.25 µL
29.75 µL

Total Mix

50µL
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